Changing of Prostate Specific Antigen Value in Patients With Covid-19

Saglik Bilimleri Universitesi

Status

Unknown

Conditions

Covid19

Prostate Specific Antigen

Treatments

Other: PSA value

Study type

Interventional

Funder types

Other

Identifiers

NCT05009186

PSA

Details and patient eligibility

About

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a worldwide pandemic in over 100 years. The disease caused by this newly discovered virus was called Covid-19. In this study, we aimed to evaluate changing of PSA value in patients with Covid-19.

Full description

Patients with positive PCR test results were included in the study. The age of the patient and urea, leukocyte, hemoglobin, platelet, urea, and creatinine values of the patients were recorded. Urinalysis and urine culture were taken from all patients. Acute phase reactants such as sedimentation, C-reaktif protein (CRP), ferritin, and fibrinogen were measured both at the time the patients applied and three weeks after the patient recovered. PSA and free PSA were also measured in the same way. Patients whose symptoms improved and the PCR test result was negative were considered as recovered.

Enrollment

100 estimated patients

Sex

Male

Ages

45 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Male patients (>45 and <70 years of age) positive PCR test results were included in the study

Exclusion criteria

The patients <45 and >70 years of age who described lower urinary tract symptoms who had urinary tract infection who a history of prostate biopsy and previous high level of PSA who history of prostatitis were excluded.